What Is Non-Invasive Prenatal Diagnosis and How Does It Work?
Learn how non-invasive prenatal diagnosis uses cell-free fetal DNA to detect genetic conditions early without risk to mother or fetus.
138 views
The method for non-invasive prenatal diagnosis involves analyzing cell-free fetal DNA (cffDNA) circulating in the maternal blood. This approach allows for the early detection of potential genetic conditions without posing risks to the fetus or the mother. It's commonly used for assessing the risk of chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome, among others. This testing is typically offered from 10 weeks of pregnancy onwards and can also provide information on the baby's sex and rhesus (Rh) blood type.
FAQs & Answers
- At what stage of pregnancy can non-invasive prenatal diagnosis be performed? Non-invasive prenatal diagnosis can typically be performed from 10 weeks of pregnancy onwards using maternal blood samples.
- What genetic conditions can be detected using non-invasive prenatal testing? Common genetic conditions detectable include chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome.
- Is non-invasive prenatal diagnosis safe for the fetus? Yes, this method is safe because it uses maternal blood samples to analyze fetal DNA, eliminating risks associated with invasive procedures.